Document › Details
Owlstone Nanotech. (6/16/14). "Press Release: Owlstone Introduces UltraFAIMS for Improved Mass Spectrometry". Cambridge & Norwalk, CT.
|Country||United States (USA)|
|Organisation 2||Loughborough University|
|Product||UltraFAIMS system (Owlstone)|
|Product 2||6460 triple quadrupole LC/MS system (Agilent)|
|Person||Cuddon, Lorna (Zyme Communications 201007– Managing Director + Founder before College Hill Life Sciences)|
A low-cost accessory for mass spectrometers that provides an additional dimension of high-speed separation by ion mobility
Owlstone Ltd, a developer of next-generation chemical sensing products and solutions, today announced the commercial launch of its UltraFAIMS series of products, developed to enhance mass spectrometry (MS) by quickly simplifying complex mass spectra, separating isobaric ions and reducing background. The new products were launched today at the 62nd ASMS Conference on Mass Spectrometry and Allied Topics, June 15th-19th 2014, Baltimore, MD.
UltraFAIMS is a miniaturized chip-based FAIMS (Field Asymmetric Ion Mobility Spectrometry) platform technology developed by Owlstone. UltraFAIMS can be interfaced with mass spectrometers to provide an additional in-source separation stage for isobaric analytes, protein and peptide charge states, large and small proteins, isomers and conformers. Miniaturizing the chip has allowed Owlstone to generate much higher field strengths than have been available in FAIMS systems up to now. This means that a greater range of analytes can be separated, at faster speeds, without compromising the system sensitivity.
The newly-launched UltraFAIMS ion filters incorporate the miniaturized FAIMS chip, and can be retrofitted onto mass spectrometers. The low-cost modules have been shown to improve mass accuracy and detection limits, increase the level of quantitation and dynamic range, reduce background and provide additional real-time separation within LC peaks. Once installed, UltraFAIMS can be turned on to provide extra separation, or turned off to allow transmission of all species simultaneously - there is no need to remove it from the system when not in use. Its small size (height, width and depth ˜ 20cm) and straightforward interface mean it can easily be added to an established laboratory setup.
Professor Colin Creaser, Head of the Centre for Analytical Science at Loughborough University, whose group has been working with a pre-production instrument, said: "Owlstone's chip-based FAIMS system is very straightforward to use and has demonstrated potential for the analysis of small molecules, peptides and proteins. We are particularly excited about its ability to enhance high-throughput mass spectrometry applications by separating target ion responses from isobaric and isomeric ions."
The product range includes:
· UltraFAIMS-A1, compatible with Agilent 6130/6150 (SQ), 6460 (QQQ), 6230 (TOF) and 6530/6540 (QTOF)
· UltraFAIMS-T1, compatible with Thermo Exactive Series & LTQ-Orbitrap
· UltraFAIMS-DK1 (developer kit), which is available for instrument developers or vendors who wish to interface with a mass spectrometer or source for which an off-the-shelf interface isn't currently available
To find out more about UltraFAIMS, visit the product page at: www.ultrafaims.com
Notes to Editors.
For more information please contact:
Lorna Cuddon, Zyme Communications
+44 (0)7811 996 942
About Owlstone: http://www.owlstonenanotech.com/
The Owlstone detector is a revolutionary dime-sized device that can be programmed to detect a wide range of chemical agents that may be present in extremely small quantities. Using leading-edge micro- and nano- fabrication techniques, Owlstone has created a complete chemical detection system that is one hundred times smaller and one thousand times cheaper than existing technologies. There are numerous applications - across industries from security and defense to automotive and healthcare - that depend on the rapid, accurate detection and measurement of chemical compounds.
Owlstone works with market leaders within these applications to integrate its detector into next generation chemical sensing products and solutions. Owlstone's technology offers a unique combination of benefits, including: small size, low manufacturing costs, minimal power consumption, reduced false-positives, and a customizable platform.
At the heart of this platform is a ground-breaking solid state sensor whose operational parameters can be fine-tuned to detect a wide range of airborne or dissolved chemical agents in extremely small quantities. Originally developed by the company's founders at the University of Cambridge, these pioneering technologies have already won Owlstone widespread commercial and academic recognition.
Record changed: 2016-03-20
More documents for Owlstone (Group)
-  Owlstone Medical. (11/1/16). "Press Release: Owlstone Medical and Imperial College Collaborate to Study Underlying Causes of Asthma Exacerbations". Cambridge....
-  Owlstone Medical. (10/4/16). "Press Release: Owlstone Medical Receives CE Mark Approval for Pediatric Disease Breathalyzer". Cambridge....
-  Owlstone Medical. (9/22/16). "Press Release: Owlstone Medical Commences Next Phase in World’s Largest Breath-based Clinical Trial for Early Cancer Detection". Cambridge....
-  Owlstone Medical. (8/25/16). "Press Release: Owlstone Medical Strengthens Management Team. Chris Hodkinson, Dr Marc van der Schee and Hamilton Scanlon Join the Company". Cambridge....
-  Owlstone Medical. (6/28/16). "Press Release: Owlstone Medical Closes $7M (£4.9M) Investment to Commercialize Disease Breathalyzer". Cambridge....
-  Owlstone Inc.. (2/16/16). "Press Release: Owlstone Medical Wins NHS Contract for STRATA, Adapting Its Disease Breathalyzer technology for Precision Medicine and Companion diagnostics (CDx)". Cambridge....
-  Owlstone Nanotech. (5/13/14). "Press Release: Owlstone Secures Share of £12.7m SBRI Healthcare Funding to Develop Lung Cancer Diagnostic Technology"....
-  Owlstone Nanotech. (7/23/10). "Press Release: Owlstone Nanotech Receives R&D100 Award. Owlstone Nanotech, Inc., in Partnership with Pacific Northwest National Laboratory, Has Been Selected as One of the 2010 R&D100 Award Winners". Suffern, NY....
-  Advance Nanotech, Inc.. (6/15/10). "Press Release: Owlstone Presents Pharmaceutical Application Data on Ultra-FAIMS". Montebello, NY....
-  Advance Nanotech, Inc.. (5/20/10). "Press Release: Owlstone Receives Industrial Application Development Order from Global Food Processing Company". Montebello, NY....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »MSC newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]